Aromatase inhibitor induced musculoskeletal syndrome: a significant problem with limited treatment options
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aromatase inhibitor induced musculoskeletal syndrome: a significant problem with limited treatment options
Authors
Keywords
Early breast cancer, Aromatase inhibitor, Arthralgia, Arthritis, Myalgia, Interventions
Journal
SUPPORTIVE CARE IN CANCER
Volume 24, Issue 5, Pages 2139-2146
Publisher
Springer Nature
Online
2015-11-10
DOI
10.1007/s00520-015-3001-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment-Associated Musculoskeletal and Vasomotor Symptoms and Relapse-Free Survival in the NCIC CTG MA.27 Adjuvant Breast Cancer Aromatase Inhibitor Trial
- (2015) Vered Stearns et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Exercise Trial of Aromatase Inhibitor–Induced Arthralgia in Breast Cancer Survivors
- (2015) Melinda L. Irwin et al. JOURNAL OF CLINICAL ONCOLOGY
- A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI
- (2014) A. Lintermans et al. BREAST CANCER RESEARCH AND TREATMENT
- Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy
- (2014) Kelley M. Kidwell et al. CANCER
- Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens
- (2014) Anneleen Lintermans et al. EUROPEAN JOURNAL OF CANCER
- Effect of Concurrent Prescription Antiarthralgia Pharmacotherapy on Persistence to Aromatase Inhibitors in Treatment-Naïve Postmenopausal Females
- (2013) Mohamed G Hashem et al. ANNALS OF PHARMACOTHERAPY
- Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study
- (2013) Natalia Garcia-Giralt et al. BREAST CANCER RESEARCH AND TREATMENT
- Symptoms of endocrine treatment and outcome in the BIG 1-98 study
- (2013) J. Huober et al. BREAST CANCER RESEARCH AND TREATMENT
- A nested case–control study of adjuvant hormonal therapy persistence and compliance and early breast cancer recurrence in women with stage I–III breast cancer
- (2013) T I Barron et al. BRITISH JOURNAL OF CANCER
- Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality
- (2013) B Makubate et al. BRITISH JOURNAL OF CANCER
- The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study
- (2013) C McCowan et al. BRITISH JOURNAL OF CANCER
- A randomised trial of electro-acupuncture for arthralgia related to aromatase inhibitor use
- (2013) Jun J. Mao et al. EUROPEAN JOURNAL OF CANCER
- Specific Adverse Events Predict Survival Benefit in Patients Treated With Tamoxifen or Aromatase Inhibitors: An International Tamoxifen Exemestane Adjuvant Multinational Trial Analysis
- (2013) Duveken B.Y. Fontein et al. JOURNAL OF CLINICAL ONCOLOGY
- Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial
- (2013) Jack Cuzick et al. LANCET
- Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer
- (2012) N. Lynn Henry et al. JOURNAL OF CLINICAL ONCOLOGY
- Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2–3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study
- (2012) J Sven D Mieog et al. LANCET ONCOLOGY
- Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer
- (2012) Heather Greenlee et al. SUPPORTIVE CARE IN CANCER
- Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesis
- (2011) A. Lintermans et al. ANNALS OF ONCOLOGY
- Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial
- (2011) Antonella L. Rastelli et al. BREAST CANCER RESEARCH AND TREATMENT
- Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms
- (2011) N. Lynn Henry et al. CANCER
- Impact of Yoga on Functional Outcomes in Breast Cancer Survivors With Aromatase Inhibitor–Associated Arthralgias
- (2011) Mary Lou Galantino et al. INTEGRATIVE CANCER THERAPIES
- Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study
- (2010) Daniel Prieto-Alhambra et al. BREAST CANCER RESEARCH AND TREATMENT
- Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
- (2010) Dawn L. Hershman et al. BREAST CANCER RESEARCH AND TREATMENT
- Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case–control study
- (2010) N L Henry et al. BRITISH JOURNAL OF CANCER
- Randomized, Blinded, Sham-Controlled Trial of Acupuncture for the Management of Aromatase Inhibitor–Associated Joint Symptoms in Women With Early-Stage Breast Cancer
- (2010) Katherine D. Crew et al. JOURNAL OF CLINICAL ONCOLOGY
- Menopausal arthralgia: Fact or fiction
- (2010) Malgorzata Magliano MATURITAS
- Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer
- (2009) Qamar J. Khan et al. BREAST CANCER RESEARCH AND TREATMENT
- Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study
- (2009) Karine Briot et al. BREAST CANCER RESEARCH AND TREATMENT
- Tolerance of adjuvant letrozole outside of clinical trials
- (2008) C. Fontaine et al. BREAST
- Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer
- (2008) C McCowan et al. BRITISH JOURNAL OF CANCER
- Role of oestrogen in the development of joint symptoms?
- (2008) Ai Lyn Tan et al. LANCET ONCOLOGY
- Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial
- (2008) Jack Cuzick et al. LANCET ONCOLOGY
- Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis
- (2008) Ivana Sestak et al. LANCET ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started